Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida (D.W.); Department of Clinical Sciences, Bioinformatics Core Facility, University of Texas Southwestern Medical Center, Dallas, Texas (R.L.); and Mathematical Bioscience Institute, (G.R.) and Center for Pharmacogenomics, Department of Cancer Biology and Genetics, College of Medicine (W.S.), Ohio State University, Columbus, Ohio
Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida (D.W.); Department of Clinical Sciences, Bioinformatics Core Facility, University of Texas Southwestern Medical Center, Dallas, Texas (R.L.); and Mathematical Bioscience Institute, (G.R.) and Center for Pharmacogenomics, Department of Cancer Biology and Genetics, College of Medicine (W.S.), Ohio State University, Columbus, Ohio.
Mol Pharmacol. 2019 Oct;96(4):430-440. doi: 10.1124/mol.119.116897. Epub 2019 Aug 9.
Cytochrome P450 3A4 isoform () transcription is controlled by hepatic transcription factors (TFs), but how TFs dynamically interact remains uncertain. We hypothesize that several TFs form a regulatory network with nonlinear, dynamic, and hierarchical interactions. To resolve complex interactions, we have applied a computational approach for estimating Sobol's sensitivity indices (SSI) under generalized linear models to existing liver RNA expression microarray data (GSE9588) and RNA-seq data from genotype-tissue expression (GTEx), generating robust importance ranking of TF effects and interactions. The SSI-based analysis identified TFs and interacting TF pairs, triplets, and quadruplets involved in CYP3A4 expression. In addition to known CYP3A4 TFs, estrogen receptor (ESR1) emerges as key TF with the strongest main effect and as the most frequently included TF interacting partner. Model predictions were validated using small interfering RNA (siRNA)/short hairpin RNA (shRNA) gene knockdown and clustered regularly interspaced short palindromic repeats (CRISPR)-mediated transcriptional activation of in biliary epithelial Huh7 cells and human hepatocytes in the absence of estrogen. Moreover, ESR1 and known CYP3A4 TFs mutually regulate each other. Detectable in both male and female hepatocytes without added estrogen, the results demonstrate a role for unliganded ESR1 in CYP3A4 expression consistent with unliganded ESR1 signaling reported in other cell types. Added estrogen further enhances ESR1 effects. We propose a hierarchical regulatory network for CYP3A4 expression directed by ESR1 through self-regulation, cross regulation, and TF-TF interactions. We also demonstrate that ESR1 regulates the expression of other P450 enzymes, suggesting broad influence of ESR1 on xenobiotics metabolism in human liver. Further studies are required to understand the mechanisms underlying role of ESR1 in P450 regulation. SIGNIFICANCE STATEMENT: This study focuses on identifying key transcription factors and regulatory networks for CYP3A4, the main drug metabolizing enzymes in liver. We applied a new computational approach (Sobol's sensitivity analysis) to existing hepatic gene expression data to determine the role of transcription factors in regulating CYP3A4 expression, and used molecular genetics methods (siRNA/shRNA gene knockdown and CRISPR-mediated transcriptional activation) to test these interactions in life cells. This approach reveals a robust network of TFs, including their putative interactions and the relative impact of each interaction. We find that ESR1 serves as a key transcription factor function in regulating CYP3A4, and it appears to be acting at least in part in a ligand-free fashion.
细胞色素 P450 3A4 同工型 () 的转录受肝转录因子 (TFs) 控制,但 TFs 如何动态相互作用尚不确定。我们假设几个 TF 形成一个具有非线性、动态和层次交互的调节网络。为了解决复杂的相互作用,我们应用了一种计算方法来估计广义线性模型下的 Sobol 敏感性指数 (SSI),并使用基因型组织表达 (GTEx) 的现有肝 RNA 表达微阵列数据 (GSE9588) 和 RNA-seq 数据,对 TF 效应和相互作用进行稳健的重要性排序。基于 SSI 的分析确定了涉及 CYP3A4 表达的 TF 和相互作用的 TF 对、三胞胎和四胞胎。除了已知的 CYP3A4 TF 外,雌激素受体 () 也成为关键 TF,具有最强的主要效应,并且是最常包含的相互作用 TF 伙伴。使用胆管上皮 Huh7 细胞和无雌激素的人肝细胞中的小干扰 RNA (siRNA)/短发夹 RNA (shRNA) 基因敲低和簇状规则间隔短回文重复 (CRISPR) 介导的转录激活来验证模型预测。此外,ESR1 和已知的 CYP3A4 TF 相互调节。在没有添加雌激素的雄性和雌性肝细胞中都可以检测到,结果表明无配体 ESR1 在 CYP3A4 表达中的作用与其他细胞类型中报道的无配体 ESR1 信号一致。添加雌激素进一步增强了 ESR1 的作用。我们提出了一个由 ESR1 通过自我调节、交叉调节和 TF-TF 相互作用指导的 CYP3A4 表达的分层调节网络。我们还表明,ESR1 调节其他 P450 酶的表达,这表明 ESR1 对人类肝脏中异生素代谢有广泛影响。需要进一步研究来了解 ESR1 在 P450 调节中的作用机制。
本研究重点关注鉴定 CYP3A4 的关键转录因子和调节网络,CYP3A4 是肝脏中主要的药物代谢酶。我们应用一种新的计算方法(Sobol 敏感性分析)来处理现有的肝基因表达数据,以确定转录因子在调节 CYP3A4 表达中的作用,并使用分子遗传学方法(siRNA/shRNA 基因敲低和 CRISPR 介导的转录激活)来在生命细胞中测试这些相互作用。这种方法揭示了一个强大的 TF 网络,包括它们的假定相互作用和每个相互作用的相对影响。我们发现 ESR1 作为一个关键的转录因子,在调节 CYP3A4 中起作用,它似乎至少部分以无配体的方式起作用。